[基于CRISPR/Cas9技术的毒素菌疫苗研究进展]

Y Wu1,2, X Zhang1, J Li1

  • 1Shandong Institute of Parasitic Diseases, Shandong First Medical University & Shandong Academy of Medical Sciences, Jining, Shandong 272033, China.

概括

这篇评论探讨了CRISPR/Cas9基因编辑用于开发针对Toxoplasma gondii的疫苗,Toxoplasma gondii是一种导致人类和动物中毒素的寄生虫. 它强调了为有效的疫苗开发创造单基因和双基因删除菌株的应用.